---
title: "Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia | NXL Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288734737.md"
description: "Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia | NXL Stock News"
datetime: "2026-06-04T06:01:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288734737.md)
  - [en](https://longbridge.com/en/news/288734737.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288734737.md)
generator: "portal-rs"
---

# Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia | NXL Stock News

Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia | NXL Stock News

### Related Stocks

- [NXL.US](https://longbridge.com/en/quote/NXL.US.md)
- [NXLIW.US](https://longbridge.com/en/quote/NXLIW.US.md)

## Related News & Research

- [Nexalin Technology Announces Reverse Stock Split | NXL Stock News](https://longbridge.com/en/news/297177039.md)
- [Nexalin Technology prices registered direct offering of 2,419,355 shares at $0.31 each](https://longbridge.com/en/news/296538267.md)
- [Teladoc’s Completed BetterHelp Trial Signals a New Phase for Digital Mental Health Investing](https://longbridge.com/en/news/297070880.md)
- [Nexalin Technology Issues $1.17 Million OID Note for $1.0 Million Proceeds](https://longbridge.com/en/news/296654800.md)
- [Nexalin Technology Announces $0.75M Direct Offering and $15M Equity Purchase Facility With Alumni Capital](https://longbridge.com/en/news/296538958.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**